Supplementary Figure 16 from Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure 16. Effect of Allo-SCT and IDH1/2 inhibitors on OS.
Authors: Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, David A. Sallman, Qianxing Mo, Onyee Chan, Ling Zhang, Nicole D. Vincelette, Xiaoqing Yu, Rinzine Sammut, Jungwon Moon, Junyoung Park, Sura-Attha Umasangtongkul, Felyschia M. Lledo, Tiffany N. Razabdouski, Chia-Ho Cheng, Dahui Qin, Kathy Mai, Somedeb Ball, Rory M. Shallis, Zhuoer Xie, Andrew T. Kuykendall, Eric Padron, Kendra Sweet, Alison R. Walker, Rami S. Komrokji, Jeffrey E. Lancet, Sandrine Niyongere, Thomas Cluzeau, Seongseok Yun
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165015281